Scilex announces stocking of FDA-approved GLOPERBA® liquid oral colchicine for gout flare prevention in US wholesalers.
Scilex Holding Company announced the stocking of GLOPERBA®, the first and only liquid oral formulation of colchicine for gout flare prevention, in US wholesalers with stocking agreements. GLOPERBA® received FDA approval as a prophylactic treatment for gout flares in adults. The company expects completion of stocking by June 12, 2024. GLOPERBA® is Scilex's third commercial product, focused on non-opioid pain management.
June 10, 2024
3 Articles